Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
Hedner
Thomas
T
Department of Clinical Pharmacology, Sahlgrenska University Hospital, Göteborg, Sweden. thomas.hedner@pharm.gu.se
Samulesson
Ola
O
Währborg
Peter
P
Wadenvik
Hans
H
Ung
Kjell-Arne
KA
Ekbom
Anders
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002074:Butanones / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D018565:Food-Drug Interactions; D006801:Humans; D008875:Middle Aged; D000077430:Nabumetone; D010003:Osteoarthritis / Q000188:drug therapy*; D013272:Stomach Diseases / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D016861:Cyclooxygenase Inhibitors; D000077430:Nabumetone